510(k) Report

510(k) · Cleared

Cleared

EndoTool SubQ 2.1

K211160510(k) TraditionalCleared Oct 28, 2021192-day reviewClass II21 CFR 868.1890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Monarch Medical Technologies, LLC · NDC Calculator, Drug Dose

Cleared on Oct 28, 2021 as substantially equivalent to K180366 (Al Pacheco and Associates, 2018) after a 192-day review. Its family tree reaches back 12 generations to 1994. 1 of the 39 devices in its family, counting itself, has a Class I recall.

Decided
Oct 28, 2021
Review
192 days
Class
Class II
Product code
NDC
Recalls
None
Predicates
1

Its longest line of descent runs back 12 generations to K941811 (1994). 38 ancestors in all, the oldest K822695 (1982). No later device cites it as a predicate yet. 1 of the 39 devices in this family, counting this one, has a Class I recall.

  1. Root · 12 generations backK941811 HP M1175A, M1176A, Component Monitoring SystemHewlett-Packard Co. · 1994
  2. 8 generations between
  3. 3 generations backK132547 Endo Tool Glucose Management System (Egms)Monarch Medical Technologies · 2014 · Recalled
  4. 2 generations backK142918 EndoTool SubQMonarch Medical Technologies · 2015
  5. 1 generation backK180366 EndoTool SubQAl Pacheco and Associates · 2018
  6. This deviceK211160 EndoTool SubQ 2.1Monarch Medical Technologies, LLC · 2021
Show all 12 generations
  1. Root · 12 generations backK941811 HP M1175A, M1176A, Component Monitoring SystemHewlett-Packard Co. · 1994
  2. 11 generations backK960934 HP M1205A Omnicare Component Monitor System Model 24Hewlett-Packard Co. · 1996
  3. 10 generations backK981376 Hewlett-Packard M1205A Viridia 24 CTHewlett-Packard Co. · 1999
  4. 9 generations backK990125 HP Viridia Component Monitoring System, Model Rev. KHewlett-Packard GmbH · 1999
  5. 8 generations backK992636 HP Carevue 9000 Clinical Information System, Model M2331AHewlett-Packard Co. · 1999 · Recalled
  6. 7 generations backK023674 Philips Drug Calculator SoftwarePhilips Medical Systems · 2002
  7. 6 generations backK061110 Glucommander PlusCollaborativemed, LLC · 2006
  8. 5 generations backK101344 G+ SystemGlytec, LLC (Formally Known AS Glucotec, Inc.) · 2010
  9. 4 generations backK113853 G+ SystemGlytec, LLC · 2012
  10. 3 generations backK132547 Endo Tool Glucose Management System (Egms)Monarch Medical Technologies · 2014 · Recalled
  11. 2 generations backK142918 EndoTool SubQMonarch Medical Technologies · 2015
  12. 1 generation backK180366 EndoTool SubQAl Pacheco and Associates · 2018
  13. This deviceK211160 EndoTool SubQ 2.1Monarch Medical Technologies, LLC · 2021

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−12K941811HP M1175A, M1176A, Component Monitoring SystemHewlett-Packard Co.1994—
−11K960934HP M1205A Omnicare Component Monitor System Model 24Hewlett-Packard Co.1996—
−10K981376Hewlett-Packard M1205A Viridia 24 CTHewlett-Packard Co.1999—
−9K990125HP Viridia Component Monitoring System, Model Rev. KHewlett-Packard GmbH1999—
−8K992636HP Carevue 9000 Clinical Information System, Model M2331AHewlett-Packard Co.19998
−7K023674Philips Drug Calculator SoftwarePhilips Medical Systems2002—
−6K061110Glucommander PlusCollaborativemed, LLC2006—
−5K101344G+ SystemGlytec, LLC (Formally Known AS Glucotec, Inc.)2010—
−4K113853G+ SystemGlytec, LLC2012—
−3K132547Endo Tool Glucose Management System (Egms)Monarch Medical Technologies20141
−2K142918EndoTool SubQMonarch Medical Technologies2015—
−1K180366EndoTool SubQAl Pacheco and Associates2018—
0 (this device)K211160EndoTool SubQ 2.1Monarch Medical Technologies, LLC2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198210
199230
199310
199410
199510
199610
199720
199810
199940
200010
200120
200220
200431
200520
200610
FIG. 1 — Lineage of K211160, 1994–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NDC device

  1. #1 K242775 InPen System App (MMT-8060 (iOS), MMT-8061…score 18.0 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K180366EndoTool SubQ
Summary page 4
…NDC, Calculator, Drug Dose Regulation: 21 CFR 868.1890, Predictive pulmonary-function value calculator Substantial Equivalence claimed to: EndoTool SubQ (K180366) Description: EndoTool SubQ 2.1 is a software application for use by trained healthcare professionals to calculate and recommend…
Al Pacheco and Associates2018—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K042873Animas Model IR1250 Insulin Infusion PumpAnimas Corp. · 2004 · 6 generations back · ◆ in the 2004 ancestors bar of FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 27 years and passes through 9 companies; a new generation was cleared every 2.6 years on median.
  • 7 of the 38 ancestors have a recall of any class; 1 has a Class I recall.

How does its category compare?

All NDC devices

NDC Calculator, Drug Dose: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · NDC

2in 2025

2007: 12008: 22010: 12012: 22014: 32015: 32016: 22017: 82018: 32019: 12020: 52021: 32023: 32024: 32025: 22026 (partial year): 4
2007high 8 (2017) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NDC

60in 2024

2014: 118 days median2015: 199 days median2017: 189 days median2018: 220 days median2020: 53 days median2021: 269 days median2023: 126 days median2024: 60 days median2026 (partial year): 90 days median
2007high 269 (2021) · low 53 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NDC

1in 2025

2016: 12017: 22018: 12019: 12022: 12025: 12026 (partial year): 2
2007high 2 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NDC

299in 2025

2008: 72009: 42010: 182011: 112012: 22013: 12014: 12015: 12016: 182017: 252018: 212019: 182020: 102021: 112022: 3472023: 4632024: 1682025: 299
2007high 463 (2023) · low 0 (2007)2025

MAUDE reports naming product code NDC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—07
20090—04
20101—018
20110—011
20122—02
20130—01
2014311801
2015319901
20162—118
20178189225
20183220121
20191—118
2020553010
20213269011
20220—1347
202331260463
20243600168
20252—1299
20264902—

What is it indicated for?

EndoTool SubQ 2.1 is a software application for use by trained healthcare professionals to calculate and recommend an individual patient’s next dose of insulin to be administered subcutaneously to manage blood glucose levels in patients with hyperglycemia including adult and pediatric patients (age 2 years and above and 12 kg or more). The software is designed to recommend the insulin dose(s) and when indicated a carbohydrate dose based on the…

Read the full statement (147 words)

EndoTool SubQ 2.1 is a software application for use by trained healthcare professionals to calculate and recommend an individual patient’s next dose of insulin to be administered subcutaneously to manage blood glucose levels in patients with hyperglycemia including adult and pediatric patients (age 2 years and above and 12 kg or more). The software is designed to recommend the insulin dose(s) and when indicated a carbohydrate dose based on the prescribing healthcare Provider’s nutritional regimen, insulin regimen, target glucose range, and patient specific characteristics.

EndoTool SubQ 2.1 logic is not a substitute for clinical reasoning but an aid for trained healthcare professionals based on obtained glucose readings and entered clinical data. Final dose recommendations for a patient must be made only after consideration of the full clinical status of the patient. No medical decision should be made based solely upon the results provided by this software program.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K211160: EndoTool SubQ 2.1.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K211160

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026